Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,840 | 53,390 | 25,810 | 25,990 | N/A |
| Receivables | 22,781 | 24,060 | 21,120 | 21,080 | N/A |
| Inventories | 14,219 | 17,140 | 13,770 | 9,190 | N/A |
| Other current assets | 153 | 3,300 | 3,140 | 10 | 0 |
| TOTAL | $99,993 | $97,890 | $63,840 | $56,270 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 38,071 | 35,590 | 44,590 | 50,560 | N/A |
| Intangibles | 9,938 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 9,785 | 16,470 | 8,290 | 8,080 | 0 |
| TOTAL | $57,794 | $52,060 | $52,880 | $58,640 | $N/A |
| Total Assets | $157,788 | $149,970 | $116,730 | $114,910 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,587 | 0 | 0 | 0 | N/A |
| Accounts payable and accrued liabilities | 45,869 | 48,280 | 35,050 | 36,290 | 0 |
| Other current liabilities | N/A | 6,750 | 2,030 | 2,060 | N/A |
| TOTAL | $58,100 | $64,270 | $52,420 | $54,360 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,339 | 19,440 | 142,240 | 137,900 | N/A |
| Deferred Revenues | 1,223 | 0 | 0 | 0 | N/A |
| Other Non-Current Liabilities | 10,091 | 10,050 | 6,570 | 8,400 | 0 |
| TOTAL | $23,393 | $40,860 | $165,390 | $165,160 | $N/A |
| Total Liabilities | $81,493 | $105,140 | $217,820 | $219,530 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 104,812 | N/A | N/A | N/A | N/A |
| Common Shares | 274,294 | 295,660 | 188,870 | 191,320 | N/A |
| Retained earnings | -779,306 | -894,580 | -830,590 | -843,270 | N/A |
| Other shareholders' equity | -41,282 | -27,360 | -25,340 | -25,990 | 0 |
| TOTAL | $76,295 | $44,820 | $-101,080 | $-104,610 | $N/A |
| Total Liabilities And Equity | $157,788 | $149,960 | $116,740 | $114,920 | $0 |